Harpoon Therapeutics (HARP) Competitor Comparison
We are evaluating the key criteria listed to compare Harpoon Therapeutics (HARP) against its competitors in the Biotechnology industry.
Market Capitalization
172 / 368Gross Profits
197 / 278Total Revenue
136 / 300EBITDA
122 / 337Free Cashflow
230 / 352Quick Ratio
301 / 357Earnings per Share
331 / 359Dividend yield
0 / 6Total Cash
283 / 358Performance 3 years
79 / 368Performance 5 years
84 / 368Performance 10 years
74 / 368Linearity 3 years
52 / 368Linearity 5 years
270 / 368Linearity 10 years
190 / 368Total Rank
142 / 368Dividend Rank
146 / 368Valuation Rank
35 / 368Piotroski Rank
167 / 368Muliplier Rank
355 / 368Total Revenue - HARP ranking 136 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.